TAMMY HUGHES: Open Payments
NPI 1376733170 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 28 payments from 15 companies in 2025. Trend: 2023 $34 · 2024 $532 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $149 |
| Amgen Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Stryker Corporation | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: Ozempic, OTEZLA, UBRELVY, FLOWTRIEVER CATHETER, S, Kerendia, TRINTELLIX, IBSRELA, REXULTI.
Industry payments across GA — which companies pay providers there.
